The	the	O	O	O	O
hematologic	hematologic	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
cefonicid	cefonicid	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
cefazedone	cefazedone	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
dog	dog	O	O	O	O
:	:	O	O	O	O
a	a	O	O	O	O
potential	potential	O	O	O	O
model	model	O	O	O	O
of	of	O	O	O	O
cephalosporin	cephalosporin	O	O	OTHERS	I
hematotoxicity	hematotoxicity	O	O	OTHERS	I
in	in	O	O	O	O
man	man	O	O	O	O
.	.	O	O	O	O

Cephalosporin	cephalosporin	O	O	OTHERS	I
antibiotics	antibiotics	O	O	O	O
cause	cause	O	O	O	O
a	a	O	O	O	O
variety	variety	O	O	O	O
of	of	O	O	O	O
hematologic	hematologic	O	O	OTHERS	I
disturbances	disturbances	O	O	OTHERS	I
in	in	O	O	O	O
man	man	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
pathogeneses	pathogeneses	O	O	O	O
and	and	O	O	O	O
hematopathology	hematopathology	O	O	O	O
of	of	O	O	O	O
which	which	O	O	O	O
remain	remain	O	O	O	O
poorly	poorly	O	O	O	O
characterized	characterized	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
need	need	O	O	O	O
for	for	O	O	O	O
a	a	O	O	O	O
well-defined	well-defined	O	O	O	O
animal	animal	O	O	O	O
model	model	O	O	O	O
in	in	O	O	O	O
which	which	O	O	O	O
these	these	O	O	O	O
blood	blood	O	O	OTHERS	I
dyscrasias	dyscrasias	O	O	OTHERS	I
can	can	O	O	O	O
be	be	O	O	O	O
studied	studied	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
four	four	O	O	O	O
subacute	subacute	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
studies	studies	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
intravenous	intravenous	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
cefonicid	cefonicid	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
cefazedone	cefazedone	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
beagle	beagle	O	O	O	O
dogs	dogs	O	O	O	O
caused	caused	O	O	O	O
a	a	O	O	O	O
dose-dependent	dose-dependent	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
anemia	anemia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
neutropenia	neutropenia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
thrombocytopenia	thrombocytopenia	O	DISEASE	OTHERS	I
after	after	O	O	O	O
1	1	O	O	O	O
-	-	O	O	O	O
3	3	O	O	O	O
months	months	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
nonregenerative	nonregenerative	O	O	O	O
anemia	anemia	O	DISEASE	OTHERS	I
was	was	O	O	O	O
the	the	O	O	O	O
most	most	O	O	O	O
compromising	compromising	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
cytopenias	cytopenias	O	O	OTHERS	I
and	and	O	O	O	O
occurred	occurred	O	O	O	O
in	in	O	O	O	O
approximately	approximately	O	O	O	O
50	50	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
dogs	dogs	O	O	O	O
receiving	receiving	O	O	O	O
400	400	O	O	O	O
-	-	O	O	O	O
500	500	O	O	O	O
mg/kg	mg/kg	O	O	O	O
cefonicid	cefonicid	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
540	540	O	O	O	O
-	-	O	O	O	O
840	840	O	O	O	O
mg/kg	mg/kg	O	O	O	O
cefazedone	cefazedone	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

All	all	O	O	O	O
three	three	O	O	O	O
cytopenias	cytopenias	O	O	OTHERS	I
were	were	O	O	O	O
completely	completely	O	O	O	O
reversible	reversible	O	O	O	O
following	following	O	O	O	O
cessation	cessation	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
;	;	O	O	O	O
the	the	O	O	O	O
time	time	O	O	O	O
required	required	O	O	O	O
for	for	O	O	O	O
recovery	recovery	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
erythron	erythron	O	O	O	O
(	(	O	O	O	O
approximately	approximately	O	O	O	O
1	1	O	O	O	O
month	month	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
considerably	considerably	O	O	O	O
longer	longer	O	O	O	O
than	than	O	O	O	O
that	that	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
granulocytes	granulocytes	O	O	O	O
and	and	O	O	O	O
platelets	platelets	O	O	O	O
(	(	O	O	O	O
hours	hours	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
few	few	O	O	O	O
days	days	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Upon	upon	O	O	O	O
rechallenge	rechallenge	O	O	O	O
with	with	O	O	O	O
either	either	O	O	O	O
cephalosporin	cephalosporin	O	O	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
hematologic	hematologic	O	O	OTHERS	I
syndrome	syndrome	O	O	OTHERS	I
was	was	O	O	O	O
reproduced	reproduced	O	O	O	O
in	in	O	O	O	O
most	most	O	O	O	O
dogs	dogs	O	O	O	O
tested	tested	O	O	O	O
;	;	O	O	O	O
cefonicid	cefonicid	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
cefazedone)-treated	cefazedone)-treated	O	O	O	O
dogs	dogs	O	O	O	O
showed	showed	O	O	O	O
a	a	O	O	O	O
substantially	substantially	O	O	O	O
reduced	reduced	O	O	O	O
induction	induction	O	O	O	O
period	period	O	O	O	O
(	(	O	O	O	O
15	15	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
5	5	O	O	O	O
days	days	O	O	O	O
)	)	O	O	O	O
compared	compared	O	O	O	O
to	to	O	O	O	O
that	that	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
exposure	exposure	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
drug	drug	O	O	O	O
(	(	O	O	O	O
61	61	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
24	24	O	O	O	O
days	days	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
observation	observation	O	O	O	O
,	,	O	O	O	O
along	along	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
rapid	rapid	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
decline	decline	O	O	O	O
in	in	O	O	O	O
red	red	O	O	O	O
cell	cell	O	O	O	O
mass	mass	O	O	O	O
parameters	parameters	O	O	O	O
of	of	O	O	O	O
affected	affected	O	O	O	O
dogs	dogs	O	O	O	O
,	,	O	O	O	O
suggests	suggests	O	O	O	O
that	that	O	O	O	O
a	a	O	O	O	O
hemolytic	hemolytic	O	O	OTHERS	I
component	component	O	O	O	O
complicated	complicated	O	O	O	O
the	the	O	O	O	O
red	red	O	O	O	O
cell	cell	O	O	O	O
production	production	O	O	O	O
problem	problem	O	O	O	O
and	and	O	O	O	O
that	that	O	O	O	O
multiple	multiple	O	O	O	O
toxicologic	toxicologic	O	O	O	O
mechanisms	mechanisms	O	O	O	O
contributed	contributed	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
cytopenia	cytopenia	O	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
conclude	conclude	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
high	high	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
cefonicid	cefonicid	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
cefazedone	cefazedone	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
dogs	dogs	O	O	O	O
can	can	O	O	O	O
induce	induce	O	O	O	O
hematotoxicity	hematotoxicity	O	O	OTHERS	I
similar	similar	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
cephalosporin-induced	cephalosporin-induced	O	O	O	O
blood	blood	O	O	OTHERS	I
dyscrasias	dyscrasias	O	O	OTHERS	I
described	described	O	O	O	O
in	in	O	O	O	O
man	man	O	O	O	O
and	and	O	O	O	O
thus	thus	O	O	O	O
provides	provides	O	O	O	O
a	a	O	O	O	O
useful	useful	O	O	O	O
model	model	O	O	O	O
for	for	O	O	O	O
studying	studying	O	O	O	O
the	the	O	O	O	O
mechanisms	mechanisms	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
disorders	disorders	O	O	O	O
.	.	O	O	O	O

